European Respiratory Review (Sep 2015)

Smoking and interstitial lung diseases

  • George A. Margaritopoulos,
  • Eirini Vasarmidi,
  • Joseph Jacob,
  • Athol U. Wells,
  • Katerina M. Antoniou

DOI
https://doi.org/10.1183/16000617.0050-2015
Journal volume & issue
Vol. 24, no. 137
pp. 428 – 435

Abstract

Read online

For many years has been well known that smoking could cause lung damage. Chronic obstructive pulmonary disease and lung cancer have been the two most common smoking-related lung diseases. In the recent years, attention has also focused on the role of smoking in the development of interstitial lung diseases (ILDs). Indeed, there are three diseases, namely respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia and pulmonary Langerhans cell histiocytosis, that are currently considered aetiologically linked to smoking and a few others which are more likely to develop in smokers. Here, we aim to focus on the most recent findings regarding the role of smoking in the pathogenesis and clinical behaviour of ILDs.